The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Bayer
University of Florida
University of Nebraska
Seagen Inc.
Shanghai Zhongshan Hospital
City of Hope Medical Center
Merck Sharp & Dohme LLC
TransThera Sciences (Nanjing), Inc.
Instituto do Cancer do Estado de São Paulo
Elevation Oncology